Transient Transfection of a Wild-Type p53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Ferraz da Costa, Danielly Cristiny ^a   Casanova, Fabiana Alves ^a   Quarti, Julia ^a   Malheiros, Maitê Santos ^a   Sanches, Daniel ^a   dos Santos, Patricia Souza ^a   Fialho, Eliane ^a   Silva, Jerson L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 7; CASPASE 9; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; RESVERATROL;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL LEVEL; CELL STRAIN A549; CELL STRAIN H1299; CELL STRAIN H460; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG SENSITIVITY; ENZYME INACTIVATION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; NICK END LABELING; P53 GENE; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROCESSING; TRANSIENT TRANSFECTION; WILD TYPE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MCF-7 CELLS; STILBENES; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84869054122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048746     Document Type: Article

References (54)

1. Mann JR, Backlund MG, DuBois RN, (2005) Mechanisms of disease: Inflammatory mediators and cancer prevention. Nat Clin Pract Oncol 2: 202-210.
2. Davis CD, Emenaker NJ, Milner JA, (2010) Cellular Proliferation, Apoptosis and Angiogenesis: Molecular Targets for Nutritional Preemption of Cancer. Seminars in Oncology 37: 243-257.
3. Surh Y-J, (2003) Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3: 768-780.
4. Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, et al. (2011) Clinical trials of resveratrol. Annals of the New York Academy of Sciences 1215: 161-169.
5. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, et al. (2007) Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties. International Journal of Cancer 120: 451-458.
6. Hong WK, Sporn MB, (1997) Recent advances in chemoprevention of cancer. Science 278: 1073-1077.
7. Saiko P, Szakmary A, Jaeger W, Szekeres T, (2008) Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutation Research/Reviews in Mutation Research 658: 68-94.
8. Kundu J, Surh Y, (2008) Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Letters 269: 243-261.
9. Pezzuto JM, (2008) Resveratrol as an Inhibitor of Carcinogenesis1,2. Pharmaceutical Biology 46: 443-573.
10. Jang M, (1997) Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes. Science 275: 218-220.
11. Signorelli P, Ghidoni R, (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. The Journal of Nutritional Biochemistry 16: 449-466.
12. Baur JA, Sinclair DA, (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery 5: 493-506.
13. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, et al. (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clinical Cancer Research 8: 893-903.
14. Shih A, (2002) Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism. Journal of Clinical Endocrinology & Metabolism 87: 1223-1232.
15. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, et al. (2003) Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Letters 190: 157-163.
16. She QB, Bode AM, Ma WY, Chen NY, Dong ZG, (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Research 61: 1604-1610.
17. Garvin S, Ollinger K, Dabrosin C, (2006) Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Letters 231: 113-122.
18. Casanova F, Quarti J, da Costa DCF, Ramos CA, da Silva JL, et al. (2012) Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest. Journal of Cellular Biochemistry 113: 2586-2596.
19. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
20. Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP, (2009) Awakening guardian angels: drugging the p53 pathway. Nature Reviews Cancer 9: 862-873.
21. Schon O, Friedler A, Bycroft M, Freund SMV, Fersht AR, (2002) Molecular Mechanism of the Interaction between MDM2 and p53. Journal of Molecular Biology 323: 491-501.
22. Bullock AN, Fersht AR, (2001) Rescuing the function of mutant p53. Nature Reviews Cancer 1: 68-76.
23. Huang C, Ma WY, Goranson A, Dong Z, (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242.
24. Lin HY, (2006) Integrin V 3 contains a receptor site for resveratrol. The FASEB Journal 20: 1742-1744.
25. Hsieh T-c, Wang Z, Hamby CV, Wu JM, (2005) Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochemical and Biophysical Research Communications 334: 223-230.
26. De Amicis F, Giordano F, Vivacqua A, Pellegrino M, Panno ML, et al. (2011) Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor gene expression via p38MAPK/CK2 signaling in human breast cancer cells. The FASEB Journal 25: 3695-3707.
27. Dong Z, (2003) Molecular mechanism of the chemopreventive effect of resveratrol. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 523-524: 145-150.
28. Weng C-J, Wu C-F, Huang H-W, Wu C-H, Ho C-T, et al. (2010) Evaluation of Anti-invasion Effect of Resveratrol and Related Methoxy Analogues on Human Hepatocarcinoma Cells. Journal of Agricultural and Food Chemistry 58: 2886-2894.
29. Li G, He S, Chang L, Lu H, Zhang H, et al. (2011) GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol. Phytomedicine 18: 704-709.
30. Li Y, Bäckesjö C-M, Haldosén L-A, Lindgren U, (2009) Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells. European Journal of Pharmacology 609: 13-18.
31. Lang FF, (2003) Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results. Journal of Clinical Oncology 21: 2508-2518.
32. Pan M-H, Lin C-L, Tsai J-H, Ho C-T, Chen W-J, (2010) 3,5,3′,4′,5′-Pentamethoxystilbene (MR-5), a Synthetically Methoxylated Analogue of Resveratrol, Inhibits Growth and Induces G1 Cell Cycle Arrest of Human Breast Carcinoma MCF-7 Cells. Journal of Agricultural and Food Chemistry 58: 226-234.
33. Bielawski K, Bielawska A, Sosnowska K, Miltyk W, Winnicka K, et al. (2006) Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells. Biochemical Pharmacology 72: 320-331.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 193: 265-275.
35. Ano Bom APD, Freitas MS, Moreira FS, Ferraz D, Sanches D, et al. (2010) The p53 Core Domain Is a Molten Globule at Low pH Functional Implications of a Partially Unfolded Structure. Journal of Biological Chemistry 285: 2857-2866.
36. Komarov PG, (1999) A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy. Science 285: 1733-1737.
37. Fimia GM, Filippi-Chiela EC, Villodre ES, Zamin LL, Lenz G, (2011) Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma Cells. PLoS ONE 6: e20849.
38. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM, (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochemical Pharmacology 64: 1375-1386.
39. Gatz SA, Keimling M, Baumann C, Dork T, Debatin KM, et al. (2008) Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and-Nbs1-dependent manner. Carcinogenesis 29: 519-527.
40. Shih A, Lin HY, Davis FB, Davis PJ, (2001) Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40: 2870-2878.
41. Lambert JMR, Gorzov P, Veprintsev DB, Söderqvist M, Segerbäck D, et al. (2009) PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain. Cancer Cell 15: 376-388.
42. Gogada R, Prabhu V, Amadori M, Scott R, Hashmi S, et al. (2011) Resveratrol Induces p53-independent, X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Bax Protein Oligomerization on Mitochondria to Initiate Cytochrome c Release and Caspase Activation. Journal of Biological Chemistry 286: 28749-28760.
43. Janicke RU, Sprengart ML, Wati MR, Porter AG, (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. The Journal of Biological Chemistry 273: 9357-9360.
44. Soussi T, Lozano G, (2005) p53 mutation heterogeneity in cancer. Biochemical and Biophysical Research Communications 331: 834-842.
45. Silva JL, Vieira TCRG, Gomes MPB, Bom PA, Lima LMTR, et al. (2010) Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins. Accounts of Chemical Research 43: 271-279.
46. Ano Bom APD, Rangel LP, Costa DCF, de Oliveira GAP, Sanches D, et al. (2012) Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: Implications for cancer. Journal of Biological Chemistry 287: 28152-28162.
47. Mahyar-Roemer M, Katsen A, Mestres P, Roemer K, (2001) Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. International Journal of Cancer 94: 615-622.
48. Mahyar-Roemer M, Roemer K, (2001) p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20: 3387-3398.
49. Marcsek ZL, Kocsis Z, Szende B, Tompa A, (2007) Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells. Cell Biology International 31: 1214-1219.
50. Reagan-Shaw S, Mukhtar H, Ahmad N, (2008) Resveratrol Imparts Photoprotection of Normal Cells and Enhances the Efficacy of Radiation Therapy in Cancer Cells. Photochemistry and Photobiology 84: 415-421.
51. Zahid M, Gaikwad NW, Ali MF, Lu F, Saeed M, et al. (2008) Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol. Free Radical Biology and Medicine 45: 136-145.
52. Baarine M, Thandapilly SJ, Louis XL, Mazue F, Yu L, et al. (2011) Pro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cells. Genes and Nutrition 6: 161-169.
53. Fujimoto A, Sakanashi Y, Matsui H, Oyama T, Nishimura Y, et al. (2009) Cytometric Analysis of Cytotoxicity of Polyphenols and Related Phenolics to Rat Thymocytes: Potent Cytotoxicity of Resveratrol to Normal Cells. Basic & Clinical Pharmacology & Toxicology 104: 455-462.
54. Marcellus RC, Teodoro JG, Charbonneau R, Shore GC, Branton PE, (1996) Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B-55 kDa protein. Cell Growth & Differentiation 7: 1643-1650.